Jeffrey R. Maranian - 15 Dec 2021 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Reporting relationship: VP Corporate Controller
Issuer ticker: SMMT
Reported as of: 15 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Dec 2021, 15:09:41 UTC
Prior SEC filing: 15 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey R. Maranian

Key filing fact

Jeffrey R. Maranian filed Form 4 for Summit Therapeutics Inc. (SMMT) on 17 Dec 2021.

Key facts

This page summarizes Jeffrey R. Maranian's Form 4 filing for Summit Therapeutics Inc. (SMMT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Dec 2021, 15:09.

Change

Previous filing in this sequence was filed on 15 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SMMT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +15,000
Change %
Price
Shares after: 15,000
Date: 15 Dec 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $4.75
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

(1) The option was granted on December 15, 2021. The shares underlying the option are scheduled to vest on December 15, 2024 (the three-year anniversary of the grant date).

Footnote F2

(2) Not applicable.